CurrentKaiser PermanentePolicy N/A

Clinical Review Criteria — Dialysis Services (In Home, Facility, Nocturnal, Short Daily, Ultrafiltration for CHF)

Clinical review criteria governing coverage determinations for standard hemodialysis, frequent (nocturnal/short-daily) hemodialysis, home dialysis, and ultrafiltration for congestive heart failure for Kaiser Foundation Health Plan of Washington members and their providers.

Policy Summary

PayerKaiser Permanente

PolicyDialysis Services (In-home, Facility, Nocturnal, Short Daily, Ultrafiltration for CHF)

Policy CodePolicy N/A

Change TypeAdministrative updatescode additions

Effective DateN/A

Next Review DateN/A

Key ActionSubmit the last 6 months of clinical notes from the requesting provider and/or specialist to support medical necessity when requesting this service.

SourceLink

POLICY UPDATE CHANGES

Merged Ultrafiltration for the Treatment of Congestive Heart Failure criteria and retitled to Dialysis Services.

Added CPT codes 90999 and 99512 to applicable codes list.

3 days/weekStandard hemodialysis frequency considered covered for ESRD

Greater Than 3 DaysFrequent (nocturnal/short-daily) stance

InsufficientEvidence conclusion for frequent home dialysis and ultrafiltration

04/17/2024Date last revised (footer)

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Determinations

Coverage summary

Coverage determinations summarized from the policy:

Standard Hemodialysis (Non-Medicare): Standard hemodialysis 3 days a week is covered for members with end stage renal disease when applicable policy criteria are met.3/week

Includes home dialysis when additional home criteria are met: member stable on dialysis; free of complications or significant concomitant disease making home dialysis unsuitable or unsafe; member or caregiver capable of completing home dialysis training and adhering to regimen; adequate caregiver available during dialysis; back-up arrangements with a facility-based dialysis center.

Frequent Hemodialysis (Nocturnal or Short-Daily): Frequent (greater than 3 days a week) hemodialysis, nocturnal or short-daily, in-home or facility, is considered not medically necessary due to insufficient evidence of improved long-term outcomes or equivalent safety compared with standard therapy.>3/week

Applies to non-Medicare members; Medicare coverage follows applicable CMS guidance.

Ultrafiltration for Congestive Heart Failure: Therapeutic ultrafiltration for treatment of congestive heart failure is considered not supported due to insufficient evidence of efficacy and safety compared with standard therapies.

Ultrafiltration is not supported as first-line therapy for acute decompensated heart failure based on available evidence.

Standard hemodialysis delivered 3 days per week is considered medically necessary for members with end-stage renal disease when applicable policy criteria are met. For home dialysis, additional conditions must be satisfied: the member is stable on dialysis; free of complications or significant comorbidity that would make home dialysis unsafe; the member or caregiver can complete a home dialysis training program and adhere to the regimen; an adequate caregiver is available during dialysis; and back-up arrangements have been made with a facility-based dialysis center. Frequent hemodialysis regimens (nocturnal or short-daily) performed greater than 3 days per week, whether in-home or in a facility, are considered not medically necessary for non-Medicare members due to insufficient evidence of improved long-term outcomes compared with standard therapy.

Ultrafiltration for the treatment of congestive heart failure is not supported by the available evidence. The literature review and MTAC assessments conclude there is insufficient evidence to demonstrate that ultrafiltration is as safe and effective as standard care for acute decompensated heart failure or that it improves long-term patient-centered outcomes; it is not recommended as first-line therapy.

Frequent hemodialysis regimens—defined in this policy as schedules performed greater than 3 days per week (including nocturnal and short-daily schedules), whether delivered at home or in a facility—are considered not medically necessary for non-Medicare members. MTAC reviews found insufficient high-quality evidence (few randomized trials and primarily uncontrolled or observational studies) to show consistent improvements in important health outcomes such as mortality, hospitalization, cardiovascular events, access survival, or transplant rate compared with standard thrice-weekly hemodialysis.

Ultrafiltration as a therapy for congestive heart failure—particularly in hospitalized patients with acute decompensated heart failure—has been evaluated in limited trials and case series. MTAC concludes there is insufficient evidence to establish the efficacy and safety of ultrafiltration compared with standard medical care (including stepped IV diuretic–based therapy). Evidence from trials such as CARESS-HF indicates potential for worse renal outcomes with ultrafiltration versus stepped pharmacologic therapy, and therefore ultrafiltration is not supported as first-line management.

Applicable Codes & Frequency

Applicable HCPCS/CPT listed (Standard Hemodialysis group)HCPCS | CPT

99512	Home visit for hemodialysis
90999	Unlisted dialysis procedure - inpatient or outpatient
E1629

Ultrafiltration codes (Medicare section)CPT

0692T

Therapeutic ultrafiltration

Standard hemodialysis frequency — key facts

Frequency3 sessions per week

ApplicabilityStandard hemodialysis (conventional) for ESRD

Coverage stanceConsidered medically necessary when policy criteria are met for non‑Medicare members

What Providers Must Do / Watch For

Documentation Required

Required clinical documentation

If requesting this service, submit clinical documentation to support medical necessity.

Last 6 months of clinical notes from requesting provider and/or specialist (include progress notes, medication changes, recent weight/volume status, intake/output, and response to diuretics).
Relevant hospital discharge summaries, dialysis records, and recent laboratory data (including serum creatinine, BUN, electrolytes) when applicable.

Step Therapy

Therapy sequencing for acute decompensated heart failure (ADHF)

For patients hospitalized with acute decompensated heart failure (ADHF), pharmacologic therapy sequencing is preferred before considering ultrafiltration.

Stepped pharmacologic therapy (e.g., escalating IV diuretics, addition of distal-acting diuretics, IV vasodilators, and inotropic agents as clinically indicated) should be attempted prior to ultrafiltration.

Background and Clinical Context

End-stage renal disease (ESRD) requires ongoing renal replacement therapy to sustain life. Kidney transplantation is the preferred treatment when feasible, but organ availability limits transplantation for many patients. Hemodialysis is commonly delivered as conventional in-center therapy consisting of three treatment sessions per week, each typically lasting 3–5 hours. Alternative regimens include nocturnal hemodialysis (longer sessions, often 6–8 hours overnight) and short-daily hemodialysis (shorter sessions performed more frequently); these may be delivered at home or in a dialysis center. While increased frequency or duration of dialysis can improve some intermediate physiologic measures, the evidence is limited and does not consistently demonstrate improved long-term patient-centered outcomes. Similarly, ultrafiltration has been studied for volume removal in acute decompensated heart failure but available trials and reviews do not provide sufficient evidence to establish clear benefit or safety compared with standard medical management.

Definitions

Conventional hemodialysis — definition

ScheduleThree sessions per week

Duration per session3 to 5 hours

Typical settingIn-center or home when additional home criteria are met

Nocturnal hemodialysis — definition

Duration per session6 to 8 hours

Frequency range3 to 7 nights per week

SettingPerformed at home or at a dialysis center (often overnight)